In July 2011 , the independent Data and Safety Monitoring Board of the Partners PrEP Study , a randomized , placebo-controlled efficacy trial of daily oral antiretroviral preexposure prophylaxis ( PrEP ) for HIV prevention among 4747 African heterosexual HIV serodiscordant couples , recommended discontinuation of the trial 's placebo arm due to demonstration of PrEP efficacy .